What is the prevalence of Becker muscular dystrophy?
How many people does Becker muscular dystrophy affect? Does it have the same prevalence in men and women? And in the different countries?
Becker muscular dystrophy is a relatively rare genetic disorder that primarily affects males. It is estimated to have a prevalence of approximately 1 in 18,450 individuals worldwide. This condition is caused by mutations in the dystrophin gene, leading to progressive muscle weakness and wasting. While less severe than Duchenne muscular dystrophy, Becker muscular dystrophy can still significantly impact an individual's quality of life. Early diagnosis and management strategies can help improve outcomes and provide support for affected individuals and their families.
Becker muscular dystrophy (BMD) is a relatively rare genetic disorder that primarily affects males. It is considered a milder form of muscular dystrophy compared to its more severe counterpart, Duchenne muscular dystrophy (DMD). BMD is caused by mutations in the dystrophin gene, which leads to the production of an abnormal or reduced amount of the dystrophin protein.
The prevalence of Becker muscular dystrophy is estimated to be around 1 in 18,450 males worldwide. However, it is important to note that prevalence rates may vary across different populations and regions. BMD typically manifests in early childhood or adolescence, with symptoms including muscle weakness and wasting, difficulty walking, and potential heart and respiratory complications.
While BMD is less common than DMD, it still significantly impacts the lives of those affected and their families. Early diagnosis and appropriate management strategies can help individuals with BMD maintain mobility and quality of life. Ongoing research and advancements in medical treatments offer hope for improved outcomes and potential future therapies for individuals living with Becker muscular dystrophy.
